These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 18790771

  • 21. siRNA targeting PLK-1 induces apoptosis of synoviocytes in rheumatoid arthritis.
    Wada M, Kawahito Y, Kimura S, Kohno M, Ishino H, Kimura M, Omoto A, Yamamoto A, Hamaguchi M, Tsubouchi Y, Tokunaga D, Hojo T, Ashihara E, Maekawa T, Yoshikawa T.
    Biochem Biophys Res Commun; 2007 Jun 01; 357(2):353-9. PubMed ID: 17434144
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Rapid functional screening of effective siRNAs against Plk1 and its growth inhibitory effects in laryngeal carcinoma cells.
    Lan H, Zhu J, Ai Q, Yang Z, Ji Y, Hong S, Song F, Bu Y.
    BMB Rep; 2010 Dec 01; 43(12):818-23. PubMed ID: 21189159
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1, shows broad-spectrum preclinical antitumor activity in multiple dosing regimens.
    Hikichi Y, Honda K, Hikami K, Miyashita H, Kaieda I, Murai S, Uchiyama N, Hasegawa M, Kawamoto T, Sato T, Ichikawa T, Cao S, Nie Z, Zhang L, Yang J, Kuida K, Kupperman E.
    Mol Cancer Ther; 2012 Mar 01; 11(3):700-9. PubMed ID: 22188812
    [Abstract] [Full Text] [Related]

  • 28. Nek2 siRNA therapy using a portal venous port-catheter system for liver metastasis in pancreatic cancer.
    Kokuryo T, Hibino S, Suzuki K, Watanabe K, Yokoyama Y, Nagino M, Senga T, Hamaguchi M.
    Cancer Sci; 2016 Sep 01; 107(9):1315-20. PubMed ID: 27316377
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. PLK-1 Silencing in Bladder Cancer by siRNA Delivered With Exosomes.
    Greco KA, Franzen CA, Foreman KE, Flanigan RC, Kuo PC, Gupta GN.
    Urology; 2016 May 01; 91():241.e1-7. PubMed ID: 26876462
    [Abstract] [Full Text] [Related]

  • 32. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y, Du XL, Wang CJ, Lin DC, Ruan X, Feng YB, Huo YQ, Peng H, Cui JL, Zhang TT, Wang YQ, Zhang H, Zhan QM, Wang MR.
    Gastroenterology; 2012 Mar 01; 142(3):521-530.e3. PubMed ID: 22108192
    [Abstract] [Full Text] [Related]

  • 33. PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer.
    Xiang B, Dong DW, Shi NQ, Gao W, Yang ZZ, Cui Y, Cao DY, Qi XR.
    Biomaterials; 2013 Sep 01; 34(28):6976-91. PubMed ID: 23777916
    [Abstract] [Full Text] [Related]

  • 34. Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform.
    Morry J, Ngamcherdtrakul W, Gu S, Reda M, Castro DJ, Sangvanich T, Gray JW, Yantasee W.
    Mol Cancer Ther; 2017 Apr 01; 16(4):763-772. PubMed ID: 28138033
    [Abstract] [Full Text] [Related]

  • 35. Occurrence of Aurora A positive multipolar mitoses in distinct molecular classes of colorectal carcinomas and effect of Aurora A inhibition.
    Herz C, Schlürmann F, Batarello D, Fichter CD, Schöpflin A, Münch C, Hauschke D, Werner M, Lassmann S.
    Mol Carcinog; 2012 Sep 01; 51(9):696-710. PubMed ID: 21739483
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR.
    Muralidharan R, Babu A, Amreddy N, Srivastava A, Chen A, Zhao YD, Kompella UB, Munshi A, Ramesh R.
    Mol Cancer Ther; 2017 Aug 01; 16(8):1470-1486. PubMed ID: 28572169
    [Abstract] [Full Text] [Related]

  • 40. PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis.
    Kumar S, Kim J.
    Biomed Res Int; 2015 Aug 01; 2015():705745. PubMed ID: 26557691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.